Changes in routine care treatment of patients with multiple myeloma in Germany – results from the MYRIAM registry 5. November 2020 Engelhardt M, Knauf W, Lipke J, Reiser M, Dörfel S, Kortüm M, Schlag R, von der Heyde E, La Rosée P, Pfannes R, Houet L, Medinger T, Jänicke M, Marschner N, 2020. Oncol Res Treat. 2020;43(suppl 4)(70):108. Download https://www.iomedico.com/wp-content/uploads/2020/11/Engelhardt_MYRIAM_DGHO2020.mp4 1st-line Panitumumab plus FOLFIRI or FOLFOX for patients with RAS wildtype metastatic colorectal cancer in Germany – Interim results of the non-interventional study VALIDATE J. Uhlig, J. Potenberg, D. Semsek, P. Stübs, C. Fichter, A. Köhler, L. Müller, M. Reiser, H.U. Siebenbach, T. Göhler, L. Jacobasch, V. Kächele, B. Weiterlesen Trifluridine/tipiracil in patients with refractory metastatic colorectal cancer in clinical routine in Germany: Interim results of the non-interventional study TACTIC – Interim results of the non-interventional study TACTIC Schwaner I, Göhler T, Decker T, Grundeis M, Sauer A, Fichter C, Moorahrend E, Kröning H, Lipke J, Kojouharoff G, Frank M, Hogrefe C, Marschner… Weiterlesen